PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a clinical study to investigate the pharmacokinetics/pharmacodynamics and
tolerability of DA-1229(Evogliptin) tabletin renal impaired patients.